| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Current Ratio | 4% | % | -36% |
| Debt-to-equity | -101% | % | 2.3% |
| Return On Equity | 32% | % | -16% |
| Return On Assets | -2248% | % | -123% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 166,010,805 | shares | 379% |
| Common Stock, Shares, Outstanding | 166,010,805 | shares | 377% |
| Entity Public Float | $5,473,916 | USD | 547391452% |
| Weighted Average Number of Shares Outstanding, Basic | 91,024,268 | shares | 233% |
| Weighted Average Number of Shares Outstanding, Diluted | 91,024,268 | shares | 233% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | $18,000 | USD | -31% |
| General and Administrative Expense | $4,143,000 | USD | -18% |
| Operating Income (Loss) | $4,161,000 | USD | 23% |
| Nonoperating Income (Expense) | $26,558,000 | USD | -11% |
| Net Income (Loss) Attributable to Parent | $30,719,000 | USD | -4.6% |
| Earnings Per Share, Basic | -1 | USD/shares | 6.2% |
| Earnings Per Share, Diluted | -1 | USD/shares | 6.2% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Assets, Current | $1,492,000 | USD | -17% |
| Assets | $1,582,000 | USD | -46% |
| Accounts Payable, Current | $16,387,000 | USD | -2.9% |
| Liabilities, Current | $26,568,000 | USD | -12% |
| Liabilities | $93,981,000 | USD | 19% |
| Retained Earnings (Accumulated Deficit) | $213,775,000 | USD | -17% |
| Stockholders' Equity Attributable to Parent | $92,399,000 | USD | -22% |
| Liabilities and Equity | $1,582,000 | USD | -46% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | $356,000 | USD | 27% |
| Net Cash Provided by (Used in) Financing Activities | $909,000 | USD | |
| Common Stock, Shares Authorized | 300,000,000 | shares | 0% |
| Common Stock, Shares, Issued | 166,010,805 | shares | 377% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $553,000 | USD | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $800,000 | USD | |
| Deferred Tax Assets, Valuation Allowance | $22,592,000 | USD | 8.8% |
| Deferred Tax Assets, Gross | $22,592,000 | USD | 8.8% |
| Deferred Tax Assets, Operating Loss Carryforwards | $7,642,000 | USD | 28% |
| Unrecognized Tax Benefits | $0 | USD | |
| Additional Paid in Capital | $121,376,000 | USD | 13% |
| Share-based Payment Arrangement, Expense | $745,000 | USD | 0% |